Cargando…
Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
BACKGROUND: Despite the increasing prevalence of Achromobacter xylosoxidans lung infection in patients with cystic fibrosis (CF), its clinical pathogenicity remains controversial. The objective of this study was to evaluate the effects of this emerging bacterium on lung disease severity in CF childr...
Autores principales: | Marsac, Charlotte, Berdah, Laura, Thouvenin, Guillaume, Sermet-Gaudelus, Isabelle, Corvol, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165377/ https://www.ncbi.nlm.nih.gov/pubmed/34084788 http://dx.doi.org/10.1183/23120541.00076-2021 |
Ejemplares similares
-
Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
por: Veschetti, Laura, et al.
Publicado: (2020) -
Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease
por: Stobbelaar, Kim, et al.
Publicado: (2016) -
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011) -
Complete Genome Sequence of Achromobacter xylosoxidans MN001, a Cystic Fibrosis Airway Isolate
por: Badalamenti, Jonathan P., et al.
Publicado: (2015) -
Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis
por: Khademi, S. M. Hossein, et al.
Publicado: (2021)